Bluecrest Capital Management LTD Has Trimmed Its Johnson & Johnson (JNJ) Stake; Harding Loevner LP Has Trimmed Its Banco Macro Sa (BMA) Stake

January 18, 2018 - By Marie Mckinney

Harding Loevner Lp decreased Banco Macro Sa (BMA) stake by 2.09% reported in 2017Q3 SEC filing. Harding Loevner Lp sold 2,730 shares as Banco Macro Sa (BMA)’s stock rose 7.03%. The Harding Loevner Lp holds 128,202 shares with $15.05M value, down from 130,932 last quarter. Banco Macro Sa now has $8.28 billion valuation. The stock decreased 0.01% or $0.01 during the last trading session, reaching $116.1. About 205,015 shares traded. Banco Macro S.A. (NYSE:BMA) has risen 43.80% since January 18, 2017 and is uptrending. It has outperformed by 27.10% the S&P500.

Bluecrest Capital Management Ltd decreased Johnson & Johnson (JNJ) stake by 47.24% reported in 2017Q3 SEC filing. Bluecrest Capital Management Ltd sold 7,878 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Bluecrest Capital Management Ltd holds 8,800 shares with $1.14M value, down from 16,678 last quarter. Johnson & Johnson now has $394.95B valuation. The stock increased 0.02% or $0.03 during the last trading session, reaching $147.01. About 3.73M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 18, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Bluecrest Capital Management Ltd increased Perrigo Co Plc (NYSE:PRGO) stake by 52,693 shares to 55,624 valued at $4.71 million in 2017Q3. It also upped Mosaic Co New (NYSE:MOS) stake by 160,135 shares and now owns 260,135 shares. Murphy Usa Inc (NYSE:MUSA) was raised too.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 EPS, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62B for 21.37 P/E if the $1.72 EPS becomes a reality. After $1.90 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It is flat, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. 28,368 were reported by Riverbridge Partners Ltd. Lagoda Inv Management Ltd Partnership stated it has 600 shares. Dimensional Fund LP owns 0.39% invested in Johnson & Johnson (NYSE:JNJ) for 6.81M shares. Horizon Inv Ltd Llc stated it has 3,587 shares or 0.2% of all its holdings. Daiwa Secs Gp holds 172,594 shares or 0.15% of its portfolio. Spc Financial Inc invested 0.37% of its portfolio in Johnson & Johnson (NYSE:JNJ). Fincl Advisory Ser reported 15,630 shares stake. Morgan Stanley owns 20.57 million shares. Trustmark Bancorporation Trust Department holds 0.69% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 46,243 shares. D Scott Neal Incorporated holds 1,277 shares. Gsa Cap Prtn Llp holds 0.25% or 28,268 shares in its portfolio. Rmb Capital Ltd Co holds 0.15% or 45,589 shares. Rhode Island-based Amica Pension Fund Board Of Trustees has invested 1.67% in Johnson & Johnson (NYSE:JNJ). Spears Abacus Advisors Ltd Liability accumulated 0.8% or 51,399 shares. Farmers Bancorp invested in 61,426 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 86 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) earned “Overweight” rating by JP Morgan on Monday, May 15. The stock of Johnson & Johnson (NYSE:JNJ) earned “Hold” rating by Jefferies on Tuesday, March 15. Vetr downgraded the stock to “Strong-Buy” rating in Monday, August 31 report. On Monday, March 14 the stock rating was upgraded by Goldman Sachs to “Neutral”. As per Wednesday, October 18, the company rating was maintained by Stifel Nicolaus. RBC Capital Markets maintained it with “Buy” rating and $138.0 target in Sunday, August 27 report. The firm has “Buy” rating by BMO Capital Markets given on Friday, June 2. The stock of Johnson & Johnson (NYSE:JNJ) earned “Outperform” rating by RBC Capital Markets on Wednesday, January 25. The rating was maintained by Jefferies on Thursday, July 14 with “Hold”. On Wednesday, August 2 the stock rating was maintained by BTIG Research with “Sell”.

Among 5 analysts covering Banco Macro SA (NYSE:BMA), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Banco Macro SA had 7 analyst reports since February 9, 2016 according to SRatingsIntel. The firm earned “Neutral” rating on Tuesday, March 29 by Credit Suisse. The company was upgraded on Monday, May 23 by Citigroup. Goldman Sachs upgraded the shares of BMA in report on Monday, September 26 to “Buy” rating. Goldman Sachs downgraded the stock to “Hold” rating in Monday, September 11 report. The stock of Banco Macro S.A. (NYSE:BMA) earned “Neutral” rating by UBS on Wednesday, June 1. The stock has “Buy” rating by Credit Suisse on Tuesday, June 13.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: